Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19201251 | 0.74 | SLC6A4 (0.45) | SLC6A4MAOA | |
| SCHEMBL28725351 | 0.71 | SLC6A4 (0.36) | SLC6A4MAOA | |
| SCHEMBL29488706 | 0.71 | SLC6A4 (0.36) | SLC6A4MAOA | |
| SCHEMBL17710286 | 0.71 | SLC6A4 (0.36) | SLC6A4MAOA | |
| SCHEMBL19201197 | 0.66 | SLC6A4 (0.40) | SLC6A4MAOA | |
| SCHEMBL17688579 | 0.65 | SLC6A4 (0.50) | SLC6A4MAOA | |
| SCHEMBL17688578 | 0.65 | SLC6A4 (0.50) | SLC6A4MAOA | |
| SCHEMBL29070030 | 0.64 | PTGS2 (0.37) | SLC6A4MAOA | |
| SCHEMBL11076527 | 0.64 | SLC6A4 (0.48) | SLC6A4MAOA | |
| Hydrochloric Acid SCHEMBL17710304 | 0.63 | SLC6A4 (0.49) | SLC6A4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200231597-A1 | BICYLIC COMPOUND ACTING AS AN INHIBITOR | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200231597-A1 | BICYLIC COMPOUND ACTING AS AN INHIBITOR | RORC, RORB, RORA | SLC6A4 4497/4885MAOA 2319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.